Updated COVID-19 Booster Available Now

Pfizer BioNTech and Moderna have each released an updated COVID-19 booster shot, known as a bivalent vaccine booster, that offers protection against multiple virus variants. The bivalent vaccine booster will replace the original monovalent booster moving ahead. Children and adults, ages 12 and up, are authorized for the Pfizer bivalent booster, while children and adults, ages 18 and up, have the option to get the Moderna bivalent shot. To learn more about how COVID-19 vaccines and booster shots are changing visit FDA.gov's COVID-19 Vaccines website. Visit the FDA's short Q&A on the bivalent vaccine here. (September 2, 2022)

cdc recommends Novavax COVID-19 Vaccine for 12-17 year olds

The CDC announced today the recommendation for another primary series COVID-19 vaccine for children and adolescents ages 12-17. The Food and Drug Administration (FDA) authorized the adjuvanted vaccine series for adults in mid-July. Further testing showed the vaccine was effective for adolescents as well. For more information on the new vaccine series for adolescents, visit Vaccines for Children and Teens and for a fact sheet on Novavax, visit Novavax COVID-19 Vaccine, Adjuvanted. Click here to read the full announcement. (August 22, 2022)


COVID-19 Real-time learning network

This resource from Infectious Diseases Society of America (ISDA) is a great website for COVID-19 practice tools, clinical guidance and research for all types of healthcare workers. Find the latest on vaccines, diagnostics and treatments and lots more at https://www.idsociety.org/covid-19-real-time-learning-network/ (July 22, 2022)


Children Ages 6 Months and Older Get Vaccine Recommendation from CDC

The CDC has signed off on the recommendation that children over the age of 6 months old receive a COVID-19 vaccine, stressing that children who have already had a COVID-19 infection will have added protection when also getting vaccinated. The recommendation followed the Food and Drug Administration authorization of two long-awaited COVID-19 vaccines for children under the age of 5 years old. 

The two vaccines include the Pfizer-BioNTech COVID-19 vaccine for ages 6 months to 4 years old and the Moderna COVID-19 vaccine for ages 6 months to 17 years old. The Pfizer-BioNTech vaccine is given in a three shot primary series while the Moderna vaccine has a two dose primary series (with a third primary dose for children who are immunocompromised).

The new CDC recommendation for children can be found here.  More information on the newly authorized vaccines can be found in Coronavirus (COVID-19) Update: FDA Authorizes Moderna and Pfizer-BioNTech COVID-19 Vaccines for Children Down to 6 Months of Age. (Updated June 27, 2022)


CDC Recommends Booster Dose for 5-11 Year Olds

On Thursday, May 19th, the Centers for Disease Control released a statement recommending booster shots for the age group 5-11 years to extend protection by the COVID-19 vaccine against coronavirus. This followed a recent emergency use authorization from the Food and Drug Administration for the Pfizer-BioNTech booster shots. With the official recommendation from the Centers for Disease Control and Prevention (CDC), the booster dose can be sought five months following the 2-shot vaccine series. The media statement, "CDC Strengthens Recommendations and Expands Eligibility for COVID-19 Booster Shots", can be found here. For more details on COVID-19 vaccines for all age groups, visit “COVID-19 Vaccines for Children and Teens" and  “Stay Up to Date with Your COVID-19 Vaccines”. Visit AAPD COVID-19 Resources for the latest information on COVID-19 that impacts pediatric dental practice. (Updated May 20, 2022)